Working together to bring your innovation to patients. Using Pfizer global expertise to find cutting-edge development & manufacturing solutions
- Drug Substances
Help you get your medicines to
patient fast
- Development
Pfizer CentreOne® offers
pharmaceutical development ...
- Drug Substances
Premier Research — the experts in locating rare patient populations. We help you design and recruit for studies to maximize data quality.
Connect with us:
Suchergebnisse
Suchergebnisse:
Vor 23 Stunden · May 31, 2024 at 8:05 a.m.·1 min read. The Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults over the age of 60. The approval makes RSV the second disease for which an mRNA vaccine has been greenlighted. There are currently two other RSV vaccines approved for adults over 60: Arexvy by GSK and Abrysvo by Pfizer.
Vor 2 Tagen · Cryoglobulinemia with pulmonary involvement is rare, and its characteristics, radiological findings, and outcomes are still poorly understood. Hong-xiao Han, Wei Su, Xinlun Tian, Dao-bin Zhou, Jian Li and Xin-xin Cao. Orphanet Journal of Rare Diseases 2024 19 :185. Research Published on: 2 May 2024.
Vor 3 Tagen · Pfizer, Inc.: Cours de bourse, graphiques, cotations, conseils boursiers, données financières, analyses et actualités en temps réel Action Pfizer, Inc. | PFE ...
Vor einem Tag · Covariates included in the models were the following: age (per decade of life), sex, rheumatic disease diagnostic group (IJD (reference), CTD, vasculitis and other inflammatory rheumatic diseases), disease activity (remission (reference), low disease activity, and moderate or high disease activity), vaccine type (Pfizer/BioNTech (reference), Moderna, AstraZeneca and other vaccines), rheumatic ...
Vor 2 Tagen · Find the latest Pfizer (PFE) stock price and news from the BBC.
Vor einem Tag · disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey. Rheumatology (Oxford) 2022;61:SI143–50. 21 Sattui SE, Liew JW, Kennedy K, et al. Early experience of COVID-19 vaccination
Vor 5 Tagen · Rare diseases The week in pharma: action, reaction and insight – week to May 24, 2024. 26-05-2024. UK pharma major AstraZeneca’s chief executive Sir Pascal Soriot outlined ambitious plans to increase revenue by nearly 75% to $80 billi ...
